We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$14.5B
AUM Growth
+$555M
Cap. Flow
-$36.8M
Cap. Flow %
-0.25%
Top 10 Hldgs %
13.62%
Holding
2,744
New
87
Increased
804
Reduced
726
Closed
78

Sector Composition

Rank Sector Weight
1 Technology 13.21%
2 Financials 13.07%
3 Healthcare 12%
4 Industrials 10.25%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRS
2226
DELISTED
Antares Pharma, Inc.
ATRS
$258K ﹤0.01%
100,490
P
2227
DELISTED
Pandora Media Inc
P
$258K ﹤0.01%
14,480
+386
+3% +$7.63K
PSEM
2228
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
$258K ﹤0.01%
19,081
CIA icon
2229
Citizens
CIA
$198M
$257K ﹤0.01%
33,876
CHUY
2230
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$257K ﹤0.01%
13,083
SPA
2231
DELISTED
Sparton
SPA
$257K ﹤0.01%
9,084
HHH icon
2232
Howard Hughes
HHH
$4.04B
$256K ﹤0.01%
2,056
+38
+2% +$5.08K
TREE icon
2233
LendingTree
TREE
$461M
$256K ﹤0.01%
5,304
FLIC
2234
DELISTED
First of Long Island Corp
FLIC
$255K ﹤0.01%
13,502
PATK icon
2235
Patrick Industries
PATK
$2.78B
$255K ﹤0.01%
19,551
RMAX icon
2236
RE/MAX Holdings
RMAX
$265M
$255K ﹤0.01%
7,448
ABCW
2237
DELISTED
ANCHOR BANCORP WISCONSIN INC COMMON STOCK
ABCW
$255K ﹤0.01%
+7,406
New +$234K
DCOM icon
2238
Dime Commercial Bancshares
DCOM
$1.82B
$254K ﹤0.01%
9,493
TTC icon
2239
Toro Company
TTC
$9.21B
$254K ﹤0.01%
7,950
+212
+3% +$6.54K
PTX
2240
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$253K ﹤0.01%
2,698
RARE icon
2241
Ultragenyx Pharmaceutical
RARE
$2.6B
$252K ﹤0.01%
5,748
SRGA
2242
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$252K ﹤0.01%
1,618
AT
2243
DELISTED
Atlantic Power Corporation
AT
$252K ﹤0.01%
93,013
FBNK
2244
DELISTED
First Connecticut Bancorp, Inc
FBNK
$252K ﹤0.01%
15,427
TREC
2245
DELISTED
Trecora Resources
TREC
$251K ﹤0.01%
17,108
WMS icon
2246
Advanced Drainage Systems
WMS
$11.3B
$250K ﹤0.01%
+10,871
New +$238K
NAVB
2247
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$250K ﹤0.01%
6,603
FMI
2248
DELISTED
Foundation Medicine, Inc.
FMI
$250K ﹤0.01%
11,239
HLT icon
2249
Hilton Worldwide
HLT
$72.2B
$249K ﹤0.01%
3,178
+84
+3% +$6.29K
AROW icon
2250
Arrow Financial
AROW
$723M
$248K ﹤0.01%
11,646
+256
+2% +$5.23K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2014 Portfolio in Review

As of Q4 2014, Metropolitan Life Insurance Company (MetLife) held 2,744 positions worth $14.5B, up 4% from $13.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2014 filing shows 87 new, 804 increased, 726 reduced and 78 closed positions. Its largest new stake was Shell Midstream Partners, L.P.: 150,000 shares worth $6.15M. The largest sale was Walgreens Boots Alliance, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2014 buy was Shell Midstream Partners, L.P.: 150,000 shares worth $6.15M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares 20+ Year Treasury Bond ETF in Q4 2014, an estimated $25.9M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2014 reduction was Walgreens Boots Alliance, cutting an estimated $35M.
  • Metropolitan Life Insurance Company (MetLife) fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $5.36M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 14% of its $14.5B portfolio in Q4 2014.
  • Metropolitan Life Insurance Company (MetLife) opened 87 new positions and closed 78 in Q4 2014.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 4% quarter-over-quarter to $14.5B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2014, filed 4 Feb 2015.